Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Breast 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Prostatic Neoplasms 17Osteoporosis 2Neoplasms 2Male Urogenital Diseases 2Vitamin D Deficiency 1Prostate Adenocarcinoma 1Fractures, Stress 1Carcinoma, Transitional Cell 1

Interventions

Zoledronic Acid 5bicalutamide 2Resistance Training 2Nutrition Assessment 2Goserelin 2Cholecalciferol 2Calcium 2Absorptiometry, Photon 2Vitamin D 1Toremifene 1Risedronic Acid 1Radiotherapy 1Lysine Acetyltransferase 5 1Gonadotropin-Releasing Hormone 1Estrogen Antagonists 1Estradiol 1Denosumab 1Calcium Gluconate 1Calcium Carbonate 1Blood Specimen Collection 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Osteoporosis × Cholecalciferol × Genitourinary × Clear all
NCT00058188 2020-12-08

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

Northwestern University

Phase 3 Terminated
53 enrolled
Genitourinary

Osteoporosis, Prostatic Neoplasms

NCT00043069 2016-12-07

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
71 enrolled
Genitourinary

Osteoporosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡